Coexpression of Stromelysin-3 and Insulin-Like Growth Factor II in Tumors of Ectodermal, Mesodermal, and Endodermal Origin: Indicator of a Fetal Cell Phenotype

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1917-1922

  Singer, Christian F ^a   Rasmussen, Audrey ^a   Lippman, Marc E ^a   Cullen, Kevin J ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METALLOPROTEINASE; SOMATOMEDIN B; STROMELYSIN 3;

ARTICLE; BREAST TUMOR; CANCER INVASION; CELL CULTURE; COLON TUMOR; CYTOLOGY; FEMALE; FETUS; FIBROBLAST; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; SARCOMA; SKIN;

BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; FETUS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR II; MATRIX METALLOPROTEINASE 11; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; PHENOTYPE; RNA, MESSENGER; SARCOMA; SKIN; TUMOR CELLS, CULTURED;

EID: 0031156702     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.6.1917     Document Type: Article

References (43)

1. Mignatti P, Rifkin DB. 1993 Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 73:161-195.
2. Duffy MJ. 1992 The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metast. 10:145-155.
3. Liotta A, Stetler-Stevenson WG. 1991 Invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 51(Suppl):5054s-5059s.
4. Clark WH. 1991 Tumor progression and the nature of cancer. Br J Cancer. 64:631-644.
5. Fidler IJ. 1990 Critical factors in the biology of human cancer metastasis. 28th G. H. A. Clowes Memorial Award Lecture. Cancer Res. 50:6130-6138.
6. Nakajima M, Chop AM. 1991 Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin Cancer Biol. 2:115-127.
7. Matrisian LM, Bowden GT. 1990 Stromelysin/transin and tumor progression. Semin Cancer Biol. 1:107-115.
8. Gottesman MM. 1990 Do proteases play a role in cancer? Semin Cancer Biol. 1:97-98.
9. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. 1993 Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 4:197-250.
10. Matrisian LM. 1992 The matrix-degrading-metalloproteinases. Bioessays 14:455-463.
11. Nagase H, Barrett AJ, Woessner FJ. 1992 Nomenclature and glossary of the matrix metalloproteinases. Matrix. 1(Suppl):421-424.
12. Liotta LA, Stetler-Stevenson WG. 1990 Metalloproteinases and cancer invasion. Semin Cancer Biol. 1:99-106.
13. Murphy G, Hembry RM, Hughes CE, Fosang AJ, Hardingham TE. 1990 Role and regulation of metalloproteinases in connective tissue turnover. Biochem Soc Transcr. 18:812-815.
14. Woessner FJ. 1991 Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 15:2145-2154.
15. Liotta LA, Tyrggvason K, Garbisa S, Foltz DH, Shafie S. 1980 Metastatic potential correlates with enzymatic degradation of basement membrane collagnes. Nature. 284:67-68.
16. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. 1992 Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52:701-708.
17. Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichel DF. 1988 Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48:5539-5545.
18. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Steller-Stevenson WG. 1991 Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst. 83:775-779.
19. Basset F, Bellocq JP, Wolf C, et al. 1990 A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 348:699-704.
20. Pei D, Majmudar G, Weiss SJ. 1994 Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem. 296:25849-25855.
21. Murphy G, Segain J-P, O'Shea M, et al. 1993 The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. J Biol Chem. 268:15435-15441.
22. Wolf C, Rouyer N, Lutz Y, et al. 1993 Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA. 90:1843-1847.
23. Yee D, Cullen KJ, Paik S, et al. 1988 Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res. 48:6691-6696.
24. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ. 1995 Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res. 55:2448-2454.
25. Giudice LC, de Zegher F, Gargosky SE, et al. 1995 Insulin-like growth factors and their binding proteins in the term and the preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 80:1548-1555.
26. Muller D, Wolf C, Abecassis J, et al. 1993 Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res. 53:165-169.
27. Rouyer N, Wolf C, Chenard MP, et al. 1994-1995 Stromelysin-3 gene expression in human cancer: an overview. Invas Metastasis. 24:269-275.
28. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N, Zwiebel JA. 1992 Insulin-like growth factor-II overexpression in MCF-7 cells induce phenotypic changes associated with malignant progression. Mol Endocrinol. 6:91-100.
29. Chirgwin JM, Przybla AE, MacDonald RJ, Rutter WJ. 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry. 18:5294-5299.
30. Sadler TW. 1995 Langman's medical embryology. Baltimore: Williams and Wilkins; 41-37.
31. Giani C, Cullen KJ, Campani D, Rasmussen A. 1996 IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemistry study. Breast Cancer Res Treat. 41:43-50.
32. Bronzert DA, Pantazis P, Antoniades HN, et al. 1987 Synthesis and secretion of platelet derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA. 84:5763-5767.
33. Heldin CH, Ek B, Ronnestrand L. 1983 Characterization of the receptor for platelet-derived growth factor in human fibroblasts. Demonstration of an inmate relationship with a 185:000-dalton substrate for the platelet-derived growth factor-stimulated kinase. J Biol Chem. 258:10054-10061.
34. Cullen KJ, Smith HS, Hill S, Paik S, Rosen N, Lippman ME. 1991 Growth factor mRNA expression in human fibroblasts from benign and malignant lesions. Cancer Res. 51:4978-4985.
35. Clemmons DR. 1984 Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. J Clin Endocrinol Metab. 58:850-856.
36. Han VKM, D'Ercole AJ, Lund PK. 1987 Cellular localization of somatomedin messenger RNA in the human fetus. Science. 236:193-197.
37. Scott J, Cowell J, Robertson ME, et al. 1985 Insulin-like growth factor-II gene expression in Wilms' tumor and embryonic tissues. Nature. 317:260-263.
38. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR. 1993 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res. 53:3721-3728.
39. Newell KJ, Witty JP, Rodgers WH, Matrisian LM. 1994 Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Cancer. 10:199-206.
40. Guo YS, Jin GF, Townsend CM, et al. 1995 Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions. J Am Coll Surg. 181:145-154.
41. Singh P, Dai B, Yallampalli C, Xu Z. 1994 Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs. Am J Physiol. 267:608-617.
42. Lamonerie T, Lavialle C, de-Galle B, Binoux M, Brison O. 1995 Constitutive or inducible overexpression of the IGF-II gene in cells of a human colon carcinoma cell line. Exp Cell Res. 261:342-351.
43. Urbansky SJ, Edwards DR, Hershfield N, et al. 1993 Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn Mol Pathol. 2:81-89.